Effects of pretreatment with long-acting gonadotropin-releasing hormone agonists on pregnancy outcomes in patients with minimal and mild peritoneal endometriosis: A retrospective study of 274 frozen-thawed embryo transfer cycles

被引:1
|
作者
Wang, Jieyu [1 ,2 ,3 ]
Wei, Minling [1 ,2 ,3 ]
Xu, Aike [1 ]
Zhang, Songying [1 ,2 ,3 ]
机构
[1] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Obstet & Gynecol,Assisted Reprod Unit, Hangzhou, Peoples R China
[2] Key Lab Reprod Dysfunct Management Zhejiang Prov, Hangzhou, Peoples R China
[3] Zhejiang Prov Clin Res Ctr Obstet & Gynecol, Hangzhou, Peoples R China
关键词
clinical pregnancy rate; endometriosis; frozen-thawed embryo transfer; live birth rate; long-acting gonadotropin-releasing hormone agonists; IN-VITRO FERTILIZATION; OVARIAN STIMULATION; INFERTILE WOMEN; GNRH AGONIST; IMPLANTATION; EXPRESSION; RECEPTIVITY; THERAPY; QUALITY; FLUID;
D O I
10.1097/MD.0000000000039553
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To investigate the effects of pretreatment with long-acting gonadotropin-releasing hormone agonist (GnRH-a) before frozen-thawed embryo transfer (FET) on pregnancy outcomes in patients after minimal-mild (stages I-II) peritoneal endometriosis surgery. A retrospective cohort study was performed from March 2018 to May 2019. Overall, 274 patients met inclusion criteria of undergoing FET after minimal/mild peritoneal endometriosis surgery. For the FET protocol, patients were divided into 2 groups: GnRH-a plus hormone replacement therapy (HRT) (group A, n = 154) and HRT-only (group B, n = 120), with the former divided into 2 subgroups receiving 1 (group A1, n = 80) or 2 doses (group A2, n = 74) of GnRH-a. Basic characteristics and pregnancy outcomes of groups A and B and groups A1 and A2 were compared. Clinical pregnancy rate (CPR) and live birth rate (LBR) were the primary outcomes and logistic regression was used to analyze independent correlation factors. The CPR and LBR in group A were 58.4% and 50.0%, respectively, and were not significantly higher than in group B (49.2% and 40.0%; respectively,chi(2) = 2.339, P = .126 and chi(2 )= 2.719, P = .099, respectively). CPR and LBR in group A1 were not significantly lower than those in group A2 (52.5% and 45.0% vs 64.9% and 55.4%, respectively; chi(2) = 2.420, P = .120 and chi(2) = 1.665, P = .197, respectively). However, group A2's CPR and LBR were significantly higher than group B's (64.9% and 55.4% vs 49.2% and 40.0%, respectively; chi(2) = 4.560, P = .023 and chi(2) = 4.375, P = .026, respectively). Logistic regression analysis showed that GnRH-a pretreatment (1 or 2 doses) had no significant effect on CPR and LBR compared with the HRT-only group. Patients with minimal-mild (stages I-II) peritoneal endometriosis surgery may not require GnRH-a pretreatment before FET.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Pretreatment with long-acting gonadotropin-releasing hormone agonists improved pregnancy outcomes after hysteroscopic multiple polypectomies: A retrospective study of 660 frozen-thawed embryo transfer cycles
    Wang, Jieyu
    Tong, Xiaomei
    Zhu, Haiyan
    Wei, Minling
    Lin, Xiaona
    Wang, Xiufen
    Yu, Huaying
    Hong, Fang
    Zhang, Songying
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2024, 63 (01): : 57 - 63
  • [2] GONADOTROPIN-RELEASING HORMONE AGONIST ADMINISTRATION PRIOR TO FROZEN-THAWED EMBRYO TRANSFER IMPROVES PREGNANCY OUTCOMES IN WOMEN WITH OVARIAN ENDOMETRIOSIS: A RETROSPECTIVE COHORT STUDY
    Ho, Nguyen-Tuong
    Hwu, Yuh Ming
    Ho, Yen-Ping
    Lin, Shyr-Yeu
    Wang, Ruey-Sheng
    Lee, Yi-Xuan
    Tan, Shun-Jen
    Kao, Shu-Huei
    Tzeng, Chii-Ruey
    FERTILITY AND STERILITY, 2023, 120 (04) : E141 - E141
  • [3] Endometrial preparation for frozen-thawed embryo transfer with or without pretreatment with gonadotropin-releasing hormone agonist
    Dal Prato, L
    Borini, A
    Cattoli, M
    Bonu, MA
    Sciajno, R
    Flamigni, C
    FERTILITY AND STERILITY, 2002, 77 (05) : 956 - 960
  • [4] Effects of artificial cycles with and without gonadotropin-releasing hormone agonist pretreatment on frozen embryo transfer outcomes
    Qi, Qianrong
    Luo, Jin
    Wang, Yaqin
    Xie, Qingzhen
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (06)
  • [5] Effects of artificial cycles with and without gonadotropin-releasing hormone agonist pretreatment on frozen embryo transfer outcomes in patients with adenomyosis
    Li, Muzi
    Xu, Lihong
    Zhao, Heng
    Du, Yanbo
    Yan, Lei
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [6] Effects of artificial cycles with and without gonadotropin-releasing hormone agonist pretreatment on frozen embryo transfer outcomes in patients with adenomyosis
    Muzi Li
    Lihong Xu
    Heng Zhao
    Yanbo Du
    Lei Yan
    Scientific Reports, 11
  • [7] Functional Ovarian Cysts in Artificial Frozen-Thawed Embryo Transfer Cycles With Depot Gonadotropin-Releasing Hormone Agonist
    Ji, Hui
    Su, Yan
    Zhang, Mianqiu
    Li, Xin
    Li, Xiuling
    Ding, Hui
    Dong, Li
    Cao, Shanren
    Zhao, Chun
    Zhang, Junqiang
    Shen, Rong
    Ling, Xiufeng
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [8] Impact of gonadotropin-releasing hormone agonist and hormone replacement therapy on pregnancy outcomes in single euploid frozen-thawed embryo transfer for patients with endometrial polyps
    Zhao, Qing
    Li, Jie
    Wang, Wei-Lin
    Liu, Ying-Bo
    Li, Jing
    Ni, Tian-Xiang
    Zhou, Wei
    Zhang, Qian
    Yan, Jun-Hao
    REPRODUCTIVE AND DEVELOPMENTAL MEDICINE, 2024, 8 (01) : 1 - 7
  • [9] Impact of gonadotropin-releasing hormone agonist and hormone replacement therapy on pregnancy outcomes in single euploid frozen-thawed embryo transfer for patients with endometrial polyps
    Zhao Qing
    Li Jie
    Wang Wei-Lin
    Liu Ying-Bo
    Li Jing
    Ni Tian-Xiang
    Zhou Wei
    Zhang Qian
    Yan Jun-Hao
    生殖与发育医学(英文), 2024, 08 (01)
  • [10] Gonadotropin-Releasing Hormone Agonist Combined with Hormone Replacement Therapy Protocol Improves the Live Birth Rate in Frozen-Thawed Embryo Transfer Cycles for Patients without Endometriosis
    Wang, Yu
    Xie, Huixia
    Shen, Ping
    Lv, Qun
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2023, 50 (08):